Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized Observation Study Using OHIO Chamber in Japanese Cedar Pollinosis
jRCTs031210276Completed
- Sponsor
- Immunomic Therapeutics, Inc.
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in Japanese cedar pollinosis and seasonal allergic rhinitis (SAR) comparing Pranlukast (Onon) pretreatment with Placebo pretreatment (2 arms). Primary endpoint: Total 3 nasal symptom scores (3TNSS) 120–180 minutes post-exposure. Started Aug 2021; status: completed.
02
Drugs
pranlukast
03
Conditions
Japanese cedar pollinosisseasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on jRCTs031210276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031210276.